Integrated BioPharma, Inc. (INBP)

OTCMKTS: INBP · Delayed Price · USD
0.745
-0.055 (-6.82%)
May 20, 2022 4:00 PM - Market closed
Market Cap22.30M
Revenue (ttm)60.04M
Net Income (ttm)6.85M
Shares Out29.93M
EPS (ttm)0.21
PE Ratio3.55
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,550
Open0.799
Previous Close0.800
Day's Range0.741 - 0.799
52-Week Range0.270 - 1.240
Beta0.27
Analystsn/a
Price Targetn/a
Earnings Daten/a

About INBP

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutrition...

IndustryPersonal Products
IPO DateOct 29, 1996
Employees147
Stock ExchangeOTCMKTS
Ticker SymbolINBP
Full Company Profile

Financial Performance

In 2021, INBP's revenue was $63.56 million, an increase of 20.45% compared to the previous year's $52.77 million. Earnings were $8.01 million, an increase of 95.06%.

Financial Statements

News

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the th...

1 week ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021

HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the q...

3 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021

HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for the ...

6 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021

HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021. Reven...

8 months ago - Accesswire

OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: INBP...

1 year ago - PRNewsWire